Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)’s traded shares stood at 12.62 million during the last session, with the company’s beta value hitting 0.40. At the close of
In the last trading session, 2.67 million Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) shares changed hands as the company’s beta touched 0.41. With the company’s per share
In recent trading session, Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) saw 2.05 million shares changing hands at last check today with its beta currently measuring 0.42. Company’s
In the last trading session, 1.42 million shares of the Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) were traded, and its beta was 0.52. Most recently the company’s
In today’s recent session, 0.73 million shares of the Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) have been traded, and its beta is 0.52. Most recently the company’s
In the last trading session, 27.45 million Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) shares changed hands as the company’s beta touched 0.53. With the company’s per share
In the last trading session, 2.4 million Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) shares changed hands as the company’s beta touched 0.52. With the company’s per share
In last trading session, Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) saw 14.31 million shares changing hands with its beta currently measuring 0.52. Company’s recent per share price
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
